Last reviewed · How we verify

NCT06670131

This Observational Study, Which is Being Implemented by Obtaining Statistical Data From a Google-form Filled Out by Students of Ukrainian Higher Education Institutions, Aims to Investigate the Epidemiological Features of Neck Pain and Possible Risk Factors

Not yet recruiting Last updated 4 November 2024
What this trial tests

trial in Cervicalgia in 441 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
30 November 2025
1 February 2026

Quick facts

Lead sponsorUkrainian Medical Stomatological Academy
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment441
Start date1 December 2024
Primary completion30 November 2025
Estimated completion1 February 2026

Conditions studied

Sponsor

Ukrainian Medical Stomatological Academy — full company profile →

Who can join

Adults 17 to 45, any sex, with Cervicalgia or Neck Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to analyze the epidemiological, demographic, social, behavioural and neuropsychological factors of neck pain in students of higher medical education institutions in Ukraine. To achieve the aim of this study, we will conduct an anonymous survey among medical students seeking master's degrees in Ukrainian higher education institutions. The questionnaire will be distributed among the student community in special chats and groups in messengers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cervicalgia

Currently open trials in the same condition.

Other Ukrainian Medical Stomatological Academy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06670131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing